Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants

Documenti analoghi

• Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
  di: Shuo Liu, et al.
  Pubblicazione: (2024)
• Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
  di: Ziteng Liang, et al.
  Pubblicazione: (2024)
• The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
  di: Yishan Lu, et al.
  Pubblicazione: (2024)
• Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
  di: Minjin Wang, et al.
  Pubblicazione: (2024)
• Chemoproteomics enables identification of coatomer subunit zeta‐1 targeted by a small molecule for enterovirus A71 inhibition
  di: Xiaoyong Li, et al.
  Pubblicazione: (2024)